Klemm J
Fortschr Med. 1977 Jul 28;95(28):1791-4.
The efficacy of Adrevil has been investigated in 35 patients suffering from arterial blood flow disorders in the lower limb. The patients were given a daily dose of 3 X 2 tablets over a period of 30 days. Changes in muscle perfusion were determined by means of the 133 Xenon muscle clearance. The perfusion volume was found to be increased by 8--12% depending on the severity of the clinical state before treatment. The effect of the drug was more pronounced in cases with severe pathological changes prior to treatment. No adverse reactions were observed.
已对35例患有下肢动脉血流障碍的患者研究了Adrevil的疗效。在30天的时间里,给这些患者每日服用3×2片的剂量。通过133氙肌肉清除率来测定肌肉灌注的变化。根据治疗前临床状态的严重程度,发现灌注量增加了8%-12%。该药物在治疗前有严重病理变化的病例中效果更明显。未观察到不良反应。